Edwards Pushes Ahead On Earlier-Than-Expected Sapien 3 Rollout
This article was originally published in The Gray Sheet
Executive Summary
Up until shortly before the FDA approved Sapien 3, Edwards did not expect the approval to come until later this year, so the U.S. rollout is still expected to be complete by year's end.